After acute hip surgery, the 1-year mortality rate is high. Therefore, this study evaluated the risk factors for 1-year mortality. The purposes of this study was first to examine the effect of integrated care on 1-year mortality in surgical patients and secondly to explore magnitude of comorbidity and complication on mortality.
Introduction
Osteoporotic hip fractures cause acute pain and loss of function and often lead to hospitalization. [1] Although hip fractures account for only <20% of all osteoporotic fractures, they constitute the majority of fracture-related health care expenditures and are the major cause of mortality in individuals older than 50 years. [2] The incidence of hip fractures is expected to increase with the aging of the population. Because most of these patients require hospitalization for treatment, the annual health care costs, currently estimated at $10.3 to $15.2 billion, are also expected to increase. [3] The principal treatment for hip fracture in elderly patients is surgery. After acute hip surgery, the 1-year mortality rates may be as high as 13 .4%. [4] Patients with hip fractures also exhibit a high incidence of comorbidities, which majorly affect mortality. A previous study demonstrated that the presence of ≥3 comorbidities is the strongest preoperative risk factor for mortality in patients with hip fractures. [5] During hospitalization, postoperative complications lead to longer hospitalization and higher medical costs. [6] Orthogeriatric care provided by geriatricians and orthopedic surgeons has a long history, and the orthogeriatric field was developed in England in the late 1950s. The form of orthogeriatric care models appeared at different models, from comanaged, multidisciplinary care by orthopedic surgeon, and geriatrician to nursing units. [7] Previous studies demonstrated that orthogeriatric care models, as compared with conventional model, appeared greater advantage in reduce mortality rates, [8, 9] shorter length of hospital stay, [9] decrease institutional costs [10] in surgical hip fracture patients. Despite the promising results of the care provided by orthogeriatricians in western counterparts, there are very few studies to reveal the benefit of integrated care model in Asian population. However, though the promising results of the care provided by orthogeriatricians, most hospitals still lack an orthogeriatrician. Therefore, our primary interest is to examine whether an integrated care by orthopedic surgeons acting like orthogeriatricians can reduce 1-year mortality. The second interest is to explore to what extent degree that the comorbidity and complication affect the 1-year mortality.
Methods

Study population and sample
This retrospective cohort study was conducted at a tertiary referral hospital, a 1300-bed hospital located in Southern Taiwan. All patients with fragile hip fracture who were aged >65 years and who underwent surgery between January 2009 and December 2010 were included in this study. The exclusion criteria were concomitant fractures other than hip fracture and concomitant injury that required surgery. A total of 383 patients were initially included in this study. After the exclusion of 48 patients with other concomitant fractures and 22 with concomitant injury that required surgery, 313 were finally enrolled in this study. A total of 106 (33.9%) of patients received care from integrated care group. This study was approved by the institutional review board of the Kaohsiung Medical University Hospital (KMUH-IRB-20120334).
Data source
Data were retrospectively derived from different data sources. For patients' clinical variables, the electrical hospital medical charts review was completed by orthopedic senior nursing specialists and reviewed by a senior orthopedic surgeon. Death information was from Taiwan national death registry and merged with patient identification. To insure the quality of data, data elements were randomly doubled check by one of authors.
Outcomes
The outcome was 1-year mortality, or time-to-event, was calculate from the date of discharge after hip fracture surgery to recorded date of death. In other words, all surgical patients were followed up to 365 days or death event, which came first.
Predictors: care model, and comorbidity and complication
The type of medical provider was categorized into a specialized hip surgeon acting like an orthogeriatrician with routine consultation of medical specialists in patients with sugar >200 mg/dL or HbA1 C higher than 8%, blood pressure >180 mmHg, heart failure, angina and dyspnea (integrated care), and into a general orthopedic surgeon (non-integrated care). In integrated care model, the comorbidities were treated by the suggestion of medical specialists after consultation. The treatment strategy with multiple comorbidities was determined after discussion with several medical specialists by the specialized hip surgeon. After discharge, the comorbidities were further cared in the clinic of medical specialists. Other orthopedic surgeons in the department as routine care (nonintegrated care group) cared all other patients.
Medical comorbidity was assessed using the Charlson comorbidity index (CCI), [11] a validated measure that consists of a weighted scale of 17 comorbidities (including cardiac, pulmonary, renal, and hepatic diseases; diabetes; cancer; and hemiplegia) and is expressed as a summative score. [12, 13] In this study, the CCI was categorized as none, 1, 2, or 3 or more comorbidities, as previously described. [14] Complication was measured by the new undesirable situation after admission including post-surgical anemia, urinary tract infection, delirium, gastro-intestinal tract bleeding, urinary retention, electrolyte imbalance, pneumonia, acute renal failure, arrthymia, acute myocardial infarction, respiratory failure, pulmonary edema, pleural effusion, stroke, hematuria, heart failure, pulmonary embolism, exacerbation of chronic obstructive pulmonary disease, ileus, implant failure, drop foot, bed sore, and sepsis.
Adjusted or control variables
The adjusted variables at the study included demographic characteristics (i.e., sex, age, and body mass index [BMI]), clinical characteristics (e.g., fracture type, cause of fracture, comorbidity, American Society of Anesthesiologists [ASA] grade, and time to surgery), surgical characteristics (e.g., transfusion, type of surgery, surgical time, blood loss, and bone grafting). The patient characteristics and clinical variables were categorized as follows: age was categorized into 65 to 69, 70 to 74, 75 to 79, and ≥80 years; BMI into underweight (BMI< 18.5), normal (BMI= 18.5-25), overweight (BMI= 25-30), and obese (BMI> 30), as per the World Health Organization classification [15] ; fracture type into intracapsular or extracapsular; and cause of fracture into slipping down, falling from stairs, or traumatic insult. The ASA grades were categorized into grades I to III and IV. Time to surgery was categorized into 24hours (early), 24-48hours, and ≥48hours (delayed), whereas the type of surgery was categorized into cannulated screws, dynamic hip screw, unipolar hemiarthroplasty, or bipolar hemiarthroplasty. Blood loss in the operative room was categorized into <471mL (mean plus one standard deviation [SD]) or ≥471mL.
Statistical analysis
Descriptive analyses were performed to reveal the numbers of the study population by integrated and non-integrated group, and survival status for demographic, patients clinical, and treatment variables. Continuous variables are tested by t test and Analysis of Variance (ANOVA), whereas, categorical variables are examined by the chi-square. We performed Cox proportional hazards regression analysis to identify the relatively risk in predicting variables, i.e., care model, overall system illness of patients (CCI), and complication (yes/no) was used to estimate 1-year mortality. Statistical significance was set at P < .05. All statistical analyses were performed using (SPSS 19.0 Inc., Chicago, IL, USA). Although ASA grade IV seemed to lead to higher 1-year mortality, this increase was not statistically significant (P = 0.094). Time to surgery were not were statistically associated with risk of 1-year death.
Results
Patient demographic characteristics between non-integrated care and integrated care groups
Treatment effectiveness between non-integrated care and integrated care groups
More patients in the integrated care group required blood transfusion, but no significant difference was observed in blood Table 3 Comparison factors related to 1-year mortality between groups. loss between the 2 groups. Although a higher proportion of the integrated care group underwent bone grafting, blood loss was not significantly higher in this group. The integrated care group exhibited longer hospitalization (11.6 ± 7.9 days) than did the non-integrated care group (7.0 ± 3.2 days) (P < .001). Moreover, the integrated care group received more consultation (2.6 ± 1.2 times) than did the non-integrated care group (0.7 ± 0.7 times) (P < .001). Besides, integrated care group received more followup of comorbidities other than orthopedics in medical department mostly in cardiology, pulmonology, and endocrinology 1 month after discharge (4.1 ± 1.3 times) than did the nonintegrated care group (1.3 ± 0.8 times) (P < .001). During hospitalization more expenditure was noted in the integrated care group (3054 ± 2177 USD) than in the non-integrated care group (2367 ± 696 USD) (P = .001). The 1-year mortality rate was much lower in the integrated care group (4.7%) than in the non-integrated care group (14.0%). The reduced mortality is significant in patients with age ≥80 (18.3-4.1%), ASA grade 4 (29.2%-0), ≥3 comorbidities (31.5-8.3%), transfusion (22.1-3.8%), and postoperative complications (21.0-4.8%) in integrated care group. The mortality is statistical significance in ASA grade (P = .017), comorbidities (P < .001), transfusion (P = .006), and postoperative complications (P = .002) in non-integrated care group, however, the mortality is not statistical significance in ASA grade, transfusion, and postoperative complications in integrated care group. The mortality can be significantly reduced in high-risk patients ( Table 3 ).
Analysis of risk factors for 1-year mortality nonintegrated care and integrated care groups
The Kaplan-Meier survival curves revealed that 1-year mortality was related to the presence of 3 or more comorbidities (P < .001), care model (P = .014), blood transfusion (P = .033), and complications (P = .005), but not fracture type, type of surgery, time to surgery, blood loss, or surgical time. The most critical risk factor was integrated care group, which significantly reduced the 1-year mortality rate ( Table 4 , Fig. 1 ).
Multiple Cox regression analysis of the risk factors for 1-year mortality revealed that patients with CCI ≥3 had higher 1-year mortality (hazard ratio [HR]: 6.35, 95% confidence interval [CI]: 1.81-22.31; P = .004). Patients in the integrated care group had lower 1-year mortality (HR: 0.33, 95% CI: 0.12-0.88; P = .027). Postoperative complications were also related to 1-year mortality (odds ratio [OR]: 2.97, 95% CI: 1.19-7.39; P = .019; Table 5 ).
Discussion
Hip fractures often lead to hospitalization with high 1-year mortality. In this study, we evaluated the risk factors related to 1year mortality and the effect of integrated care performed by orthopedic surgeons like orthogeriatricians. Multiple consultations for treating comorbidities during hospitalization with intergraded care by specialized hip surgeons and treatment of comorbidities in Medical clinic after discharge significantly reduced 1-year mortality.
This study demonstrated that the presence of ≥3 comorbidities and the occurrence of postoperative complications were associated with high 1-year mortality, consistent with the findings of previous studies. [16, 17] In the present study, the presence of >3 comorbidities and the occurrence of complications during hospitalization, but not age, male sex, or ASA grade, were related to 1-year mortality, although the prefracture activities of daily living index have also been inferred to be related to comorbidities. A common finding is that a higher CCI leads to higher 1-year mortality. In the present study, the mortality rate was 6.35 times higher in those with >3 comorbidities than in those without comorbidities. Roche et al [5] reported higher 1-year mortality in patients with a CCI of ≥3 (OR: 2.4). Vestergaard et al [17] reported a 1-year mortality rate of 19%, with an annual increase of 1.8%, but their major cause was the fracture event, rather than pre-existing comorbidities. Recently, Mariconda et al [16] reported a 1-year mortality rate of 18.8%, which was significantly related to an age of >80 years, male sex, ASA grade, prefracture activities of daily living index, and complications during hospitalization. Their study did not state that a special care model was applied for patients with hip fractures. Sircar et al [18] reported less complications in patients undergoing early surgery (14.7%) and more complications in those undergoing delayed surgery (33.3%). Similarly, Lefaivre et al [19] reported more complications in patients undergoing delayed surgery (OR: 2.21). In the present study, delayed surgery was not related to 1-year mortality. Treatment of comorbidities preoperatively led to delay surgery but not increased 1-year mortality. The effect of delay surgery may need further studies to validate. However, the most crucial finding of this study is that 1-year mortality rate of 4.7% and a 67% reduction in mortality was achieved in integrated care group. This finding has not been reported previously.
Because of the unavailability of an orthogeriatrician or a cocare system at the time of the study, orthopedic surgeons had to care for patients through multiple consultations, if necessary, before finally making a care decision. In this situation, the care experience of the medical provider is extremely crucial, particularly for more effective decision-making and for reducing mortality. Encouraging patients with multiple comorbidities to keep treatment after discharge is extremely crucial. Although hospitalization was 11.6 days, expenditure was only US$3054. Because the medical cost is much lower in Taiwan than in the United States, longer hospitalization for improved control of patients' comorbidities may be beneficial in reducing the 1-year mortality rate despite the increase in expenditure. Although the integrated care group had longer hospitalization with more expenditure, more consultation during hospitalization, more follow-up of comorbidities 1 month after discharge and more expenditure, the group achieved a much lower 1-year mortality rate. The most significant difference is reducing mortality in highrisk patients such as age ≥80, ASA grade 4, ≥3 comorbidities, transfusion, and postoperative complications.
Because patients with hip fracture usually exhibit one or more comorbidities and because surgical intervention is required, the involvement of an orthogeriatrician in the management of certain conditions is desirable. A previous study reported that the co-care of patients with hip fracture by an orthogeriatrician could reduce mortality. The co-care of patients by orthopedic surgeons and geriatricians can reduce hospitalization to 4.3 days, the 30-day readmission rate to 10.4%, and the 17-month reoperation rate to 1.9%. The cost of care is US$15,188 if the 1-year mortality rate is 21.2%. [20] One review reported that the 1-year mortality in 4 studies decreased from 17.71% in the control group (n = 1432) to 11.68% in the integrated care group (n = 1340). [21] Vidan et al [8] reported that a joint model of care through admission to a dedicated orthopedic ward with shared responsibility for the patient by the orthopedic surgeon and geriatrician considerably reduced hospital mortality from 5.5% to 0.6%, but the decrease in 1-year mortality was not substantial (which decreased from 25.3% to 19.9%; P = .18). Leung et al [22] also reported that patients managed by an orthopedic team with regular geriatrician review and multidisciplinary input on patient care reduced the 1year mortality rate from 20.4% to 11.6%. In this study, we found less mortality rate in patients with higher risks; for example; age ≥80, ASA grade 4, ≥3 comorbidities, transfusion, and postoperative complications.
In the present study, integrated care group led to a 1-year mortality rate of 4.7%. The cause of death in hip fracture patients is comorbidity related, but no fracture itself related. We infer that encouraging the patients to receive treatment of comorbidity at the Medical departments such as cardiology, endocrinology, and pulmonology may be the most important factor to reduce 1-year mortality rate. Nevertheless, co-care with geriatric specialists focusing on patients with hip fracture is still recommended to reduce mortality, particularly when patients exhibit >3 comorbidities.
Limitations
This study had a number of limitations. First, this is a retrospective cohort study not a prospective randomized control study. The results need further confirmation. Second, the numbers of patients are still small. Third, the medical costs after discharge and re-admission rates were not evaluated. Fourth, patients with concomitant fractures other than hip fracture and concomitant injury that required surgery was excluded which may lower 1-year mortality. Even the limitations above, we found treatment of comorbidity is an important factor to reduce 1-year mortality after hip fracture.
Conclusions
Improving care quality during hospitalization and encouraging the patients to treat comorbidities after discharge can reduce mortality after hip fracture.
